177 related articles for article (PubMed ID: 36350013)
1. Site-Specific Albumin-Selective Ligation to Human Serum Albumin under Physiological Conditions.
Yu X; Ruan M; Wang Y; Nguyen A; Xiao W; Ajena Y; Solano LN; Liu R; Lam KS
Bioconjug Chem; 2022 Dec; 33(12):2332-2340. PubMed ID: 36350013
[TBL] [Abstract][Full Text] [Related]
2. Site-selective labeling of a lysine residue in human serum albumin.
Asano S; Patterson JT; Gaj T; Barbas CF
Angew Chem Int Ed Engl; 2014 Oct; 53(44):11783-6. PubMed ID: 25196737
[TBL] [Abstract][Full Text] [Related]
3. Chromatographic studies of chlorpropamide interactions with normal and glycated human serum albumin based on affinity microcolumns.
Tao P; Li Z; Matsuda R; Hage DS
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Oct; 1097-1098():64-73. PubMed ID: 30205233
[TBL] [Abstract][Full Text] [Related]
4. Characterization of tolazamide binding with glycated and normal human serum albumin by using high-performance affinity chromatography.
Tao P; Li Z; Woolfork AG; Hage DS
J Pharm Biomed Anal; 2019 Mar; 166():273-280. PubMed ID: 30682693
[TBL] [Abstract][Full Text] [Related]
5. Is the Sudlow site I of human serum albumin more generous to adopt prospective anti-cancer bioorganic compound than that of bovine: A combined spectroscopic and docking simulation approach.
Joshi R; Jadhao M; Kumar H; Ghosh SK
Bioorg Chem; 2017 Dec; 75():332-346. PubMed ID: 29096094
[TBL] [Abstract][Full Text] [Related]
6. Spectroscopic analysis of the impact of oxidative stress on the structure of human serum albumin (HSA) in terms of its binding properties.
Maciążek-Jurczyk M; Sułkowska A
Spectrochim Acta A Mol Biomol Spectrosc; 2015 Feb; 136 Pt B():265-82. PubMed ID: 25448930
[TBL] [Abstract][Full Text] [Related]
7. BTK-inhibitor drug covalent binding to lysine in human serum albumin using LC-MS/MS.
Muste C; Gu C
Drug Metab Pharmacokinet; 2022 Feb; 42():100433. PubMed ID: 34896750
[TBL] [Abstract][Full Text] [Related]
8. Human serum albumin-imprinted polymers with high capacity and selectivity for abundant protein depletion.
Lu W; Wang S; Liu R; Guan Y; Zhang Y
Acta Biomater; 2021 May; 126():249-258. PubMed ID: 33722786
[TBL] [Abstract][Full Text] [Related]
9. Glycation of human serum albumin impairs binding to the glucagon-like peptide-1 analogue liraglutide.
Gajahi Soudahome A; Catan A; Giraud P; Assouan Kouao S; Guerin-Dubourg A; Debussche X; Le Moullec N; Bourdon E; Bravo SB; Paradela-Dobarro B; Álvarez E; Meilhac O; Rondeau P; Couprie J
J Biol Chem; 2018 Mar; 293(13):4778-4791. PubMed ID: 29414771
[TBL] [Abstract][Full Text] [Related]
10. High-Performance affinity chromatographic studies of repaglinide and nateglinide interactions with normal and glyoxal- or methylglyoxal-modified human albumin serum.
Ovbude ST; Tao P; Li Z; Hage DS
J Pharm Biomed Anal; 2021 Jul; 201():114097. PubMed ID: 33933705
[TBL] [Abstract][Full Text] [Related]
11. Nickel(II) transport in human blood serum. Studies of nickel(II) binding to human albumin and to native-sequence peptide, and ternary-complex formation with L-histidine.
Glennon JD; Sarkar B
Biochem J; 1982 Apr; 203(1):15-23. PubMed ID: 7103934
[TBL] [Abstract][Full Text] [Related]
12. Development of mammalian serum albumin affinity purification media by peptide phage display.
Sato AK; Sexton DJ; Morganelli LA; Cohen EH; Wu QL; Conley GP; Streltsova Z; Lee SW; Devlin M; DeOliveira DB; Enright J; Kent RB; Wescott CR; Ransohoff TC; Ley AC; Ladner RC
Biotechnol Prog; 2002; 18(2):182-92. PubMed ID: 11934284
[TBL] [Abstract][Full Text] [Related]
13. Identification of CJC-1131-albumin bioconjugate as a stable and bioactive GLP-1(7-36) analog.
Léger R; Thibaudeau K; Robitaille M; Quraishi O; van Wyk P; Bousquet-Gagnon N; Carette J; Castaigne JP; Bridon DP
Bioorg Med Chem Lett; 2004 Sep; 14(17):4395-8. PubMed ID: 15357960
[TBL] [Abstract][Full Text] [Related]
14. Multivalent Albumin-Neonatal Fc Receptor Interactions Mediate a Prominent Extension of the Serum Half-Life of a Therapeutic Protein.
Yang B; Kwon I
Mol Pharm; 2021 Jun; 18(6):2397-2405. PubMed ID: 33983743
[TBL] [Abstract][Full Text] [Related]
15. Switching of Trp-214 intrinsic rotamer population in human serum albumin: An insight into the aftermath of embracing therapeutic bioorganic luminophore azapodophyllotoxin into sudlow site I.
Mukherjee S; Ganorkar K; Kumar A; Sehra N; Ghosh SK
Bioorg Chem; 2019 Mar; 84():63-75. PubMed ID: 30481647
[TBL] [Abstract][Full Text] [Related]
16. Probing the Sudlow binding site with warfarin: how does gold nanocluster growth alter human serum albumin?
Russell BA; Mulheran PA; Birch DJ; Chen Y
Phys Chem Chem Phys; 2016 Aug; 18(33):22874-8. PubMed ID: 27480626
[TBL] [Abstract][Full Text] [Related]
17. Identification of Lys190 as the primary binding site for pyridoxal 5'-phosphate in human serum albumin.
Bohney JP; Fonda ML; Feldhoff RC
FEBS Lett; 1992 Feb; 298(2-3):266-8. PubMed ID: 1544460
[TBL] [Abstract][Full Text] [Related]
18. Enhanced therapeutic potential of antibody fragment via IEDDA-mediated site-specific albumin conjugation.
Go EB; Lee JH; Cho JH; Kwon NH; Choi JI; Kwon I
J Biol Eng; 2024 Apr; 18(1):23. PubMed ID: 38576037
[TBL] [Abstract][Full Text] [Related]
19. Insights into graphene oxide interaction with human serum albumin in isolated state and in blood plasma.
Taneva SG; Krumova S; Bogár F; Kincses A; Stoichev S; Todinova S; Danailova A; Horváth J; Násztor Z; Kelemen L; Dér A
Int J Biol Macromol; 2021 Apr; 175():19-29. PubMed ID: 33508363
[TBL] [Abstract][Full Text] [Related]
20. Multi-spectroscopic and molecular modeling studies of interaction between two different angiotensin I converting enzyme inhibitory peptides from gluten hydrolysate and human serum albumin.
Assaran Darban R; Shareghi B; Asoodeh A; Chamani J
J Biomol Struct Dyn; 2017 Dec; 35(16):3648-3662. PubMed ID: 27897084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
